We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost effectiveness of moderate to severe psoriasis therapy with etanercept and ustekinumab in the United States.
- Authors
Villacorta, Reginald; Hay, Joel W; Messali, Andrew
- Abstract
Limited information is available on the cost effectiveness of ustekinumab and alternative biologic treatments in a United States (US) setting. Given the recent head-to-head clinical trial study of ustekinumab and etanercept, an economic model comparing the two treatments can be constructed. Etanercept and ustekinumab are indicated for the treatment of chronic moderate to severe plaque psoriasis in adult patients who are candidates for phototherapy or systemic therapy.
- Publication
PharmacoEconomics, 2013, Vol 31, Issue 9, p823
- ISSN
1179-2027
- Publication type
Journal Article
- DOI
10.1007/s40273-013-0078-x